Episode 225: ASCO GU 2023: Brian Shuch, MD discusses the ZIRCON Phase III Study of girentuximab PET/CT imaging in RCC
Release Date:
Brian Shuch, MD, discusses the ZIRCON Phase III kidney cancer imaging study to determine the identification and characterization abilities of TLX250-CDx for clear cell renal cell carcinoma that was presented at the 2023 ASCO GU Cancers Symposium. Dr. Shuch is the Director of the University of California, Los Angeles Kidney Cancer Program, and an Associate Professor of Urology.
Episode 225: ASCO GU 2023: Brian Shuch, MD discusses the ZIRCON Phase III Study of girentuximab PET/CT imaging in RCC